enGene Therapeutics, Inc. (ENGN)
2.41
+0.13
(+5.70%)
USD |
NASDAQ |
Nov 13, 16:00
2.33
-0.08
(-3.32%)
After-Hours: 19:59
enGene Therapeutics Price : 2.41 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 2.41 | 2.51 | 2.17 | 2.41 | 3.721M |
| Nov 12, 2026 | 1.93 | 2.35 | 1.90 | 2.28 | 11.91M |
| Nov 11, 2026 | 1.70 | 1.81 | 1.63 | 1.80 | 2.766M |
| Nov 10, 2026 | 1.76 | 1.76 | 1.63 | 1.67 | 741191.0 |
| Nov 09, 2026 | 1.75 | 1.80 | 1.70 | 1.77 | 848999.0 |
| Nov 06, 2026 | 1.68 | 1.775 | 1.632 | 1.75 | 1.427M |
| Nov 05, 2026 | 1.70 | 1.71 | 1.65 | 1.68 | 624425.0 |
| Nov 04, 2026 | 1.585 | 1.75 | 1.575 | 1.72 | 1.446M |
| Nov 03, 2026 | 1.47 | 1.63 | 1.45 | 1.62 | 937137.0 |
| Nov 02, 2026 | 1.55 | 1.55 | 1.45 | 1.45 | 587187.0 |
| Oct 30, 2026 | 1.53 | 1.55 | 1.46 | 1.53 | 1.198M |
| Oct 29, 2026 | 1.57 | 1.62 | 1.52 | 1.53 | 690365.0 |
| Oct 28, 2026 | 1.54 | 1.600 | 1.535 | 1.58 | 997470.0 |
| Oct 27, 2026 | 1.625 | 1.625 | 1.55 | 1.55 | 365261.0 |
| Oct 26, 2026 | 1.57 | 1.625 | 1.554 | 1.58 | 657823.0 |
| Oct 23, 2026 | 1.55 | 1.575 | 1.54 | 1.56 | 730199.0 |
| Oct 22, 2026 | 1.619 | 1.65 | 1.57 | 1.58 | 554579.0 |
| Oct 21, 2026 | 1.68 | 1.681 | 1.59 | 1.63 | 1.109M |
| Oct 20, 2026 | 1.60 | 1.72 | 1.59 | 1.67 | 1.120M |
| Oct 19, 2026 | 1.66 | 1.70 | 1.58 | 1.58 | 783845.0 |
| Oct 16, 2026 | 1.73 | 1.749 | 1.65 | 1.67 | 1.160M |
| Oct 15, 2026 | 1.61 | 1.735 | 1.58 | 1.71 | 1.177M |
| Oct 14, 2026 | 1.60 | 1.62 | 1.56 | 1.56 | 943530.0 |
| Oct 13, 2026 | 1.69 | 1.70 | 1.62 | 1.63 | 914086.0 |
| Oct 12, 2026 | 1.73 | 1.74 | 1.69 | 1.70 | 462719.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Aurinia Pharmaceuticals, Inc. | 15.73 |
| Medicus Pharma Ltd. | 1.95 |
| Xenon Pharmaceuticals, Inc. | 40.48 |
| Psyence Biomedical Ltd. | 3.145 |
| Agenus, Inc. | 6.73 |
Price Related Metrics
| PEG Ratio | -0.1189 |
| Price to Book Value | 0.7013 |
| Earnings Yield | -86.32% |
| Market Cap | 161.50M |
| PEGY Ratio | -0.1189 |